Lionco Pharmaceutical Group Co Ltd A

SHSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:00

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeSHSE

Market Capitalization5,157.49 mln

Float325 mln

Piotroski F-Score

4 / 9

Borderline

Beneish M-Score

-2.75

Likely reliable

Relative Strength

2 / 100

Severely lagging

Debt / Equity

0.50

Moderate leverage

Pre-Tax Margin

-33%

Deeply loss-making

ROE

-20.33

Deeply negative

Business Description

Founded in 2003 and headquartered in Shannan, China, Lionco Pharmaceutical Group develops and sells a wide range of medicines across the country. Its products address many common and serious health conditions, including heart disease, infections, digestive disorders, and cancer.

Key Fundamentals

EPS-0.20

ROE-20.33

RPS0.57

ROIC-9.49

ROA-11.83

Interest Cover-3.71

EBITDA, mln-78.47

EV / EBITDA-58.74

EV / EBIT-40.35

Revenue, mln408

EV / Revenue11.29

Quote Details

Last 5.82

Change -0.51 (-8.06%)

Open 5.99

Volume 51,579,124

Turnover 300,190,496

Average Volume 41,210,296

Financial Ratios

Pre-Tax Profit Margin-33

Leverage Ratio1.75

Current Ratio1.22

Price / Book6.96

Price / Tangible Book8.12

Debt / Equity0.50

Price / Sales10.88

Financial Strength

Altman Z-Score5.03

Piotroski F-Score 4 / 9

Beneish M-Score-2.75

Price to Intrinsic Value19.78

Shiller PE Ratio158

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-18.49%	1 / 100
1 Month	-1.36%	79 / 100
2 Months	-20.27%	17 / 100
6 Months	32.88%	98 / 100
1 Year	10.44%	82 / 100